Short term insulin treatment prevents the diabetogenic action of streptozotocin in rats

Endocrinology

Volumn 138, Issue 1, 1997, Pages 62-68

  Thulesen, Jesper ^a,b   Ørskov, Cathrine ^a   Holst, Jens Juul ^a   Poulsen, Steen Seier ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER; INSULIN; INSULIN ZINC SUSPENSION; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; GLUCOSE TRANSPORT; HYPERGLYCEMIA; INSULIN TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0031014350     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.1.4827     Document Type: Article

References (34)

1. Herr RR, Eble TE, Bergy ME, Jahnke HK 1959-60 Isolation and characterization of streptozotocin. Antibiotics Annu 7:236-240
2. Fukumoto H, Seino S, Imura H, Seino Y, Eddy RL, Fukushima Y, Byers MG, Shows TB, Bell GI 1988 Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein. Proc Natl Acad Sci USA 85:5434-5438
3. Schnedl WJ, Ferber S, Johnson JH, Newgard CB 1994 STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells. Diabetes 43:1326-1333
4. Thorens B 1992 Molecular and cellular physiology of GLUT-2, a high-Km facilitated diffusion glucose transporter. Int Rev Cytol 137A:209-238
5. Okamoto H 1981 Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes. Mol Cell Biochem 37:43-61
6. Okamoto H 1985 The role of poly (ADP-ribose) synthetase in the development of insulin-dependent diabetes and islet B-cell regeneration. Biomed Biochim Acta 44:15-20
7. Okamoto H 1985 Molecular basis of experimental diabetes: degeneration, oncogenesis and regeneration of pancreatic b-cells of islets of Langerhans. Bioessays 2:15-21
8. Yamamoto H, Uchigata Y, Okamoto H 1981 DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin. Biochem Biophys Res Commun 103:1014-1020
9. Atkinson MA, Maclaren NK, Luchetta R 1990 Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39:933-937
10. Gotfredsen C, Buschard K, Frandsen E 1985 Reduction of diabetes incidence of BB-Wistar rats by early prophylactic insulin treatment of diabetes prone animals. Diabetologia 28:933-935
11. Chen L, Alam T, Johnson JH, Hughes S, Newgard CB 1990 Regulation of beta-cell glucose transporter gene expression. Proc Natl Acad Sci USA 87:4088-4092
12. Rasch R 1979 Control of blood glucose levels in the streptozotocin diabetic rat using long-acting heat-treated insulin. Diabetologia 16:185-190
13. Newgard CB, Holst JJ 1981 Heterogenieity of somatostatin-like immunoreactivity in extracts of porcine, canine and human pancreas. Acta Endocrinol (Copenh) 89:564-572
14. Albano JDM, Ekin RP, Maritz G, Turner RC 1972 The sensitive precise radioimmunoassay of serum insulin relying on charcoal-separation on bound and free hormone moities. Acta Endocrinol (Copenh) 70:487-509
15. Holst JJ 1980 Evidence that glicentin contains the entire sequence of glucagon. Biochem J 187:337-343
16. Holst JJ 1982 Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochem J 207:381-388
17. Sternberger L 1974 Immunocytochemistry. Wiley and Sons, New York
18. De Vos A, Heimberg H, Quartier E, Huypens P, Bouwens L, Pipeleers D, Schuit F 1995 Human and rat β-cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 96:2489-2495
19. Tuch BE, Turtle JR, Simeonovic CJ 1989 Streptozotocin is not toxic to the human fetal B cell. Diabetologia 32:678-684
20. Yamamoto H, Uchigata Y, Okamoto H 1981 Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 294:284-286
21. Dulin WE, Beatrice MW, Kalamazoo MS 1969 Studies on the ability of compounds to block the diabetogenic activity of streptozotocin. Diabetes 18:459-466
22. Masiello P, Cubeddu TL, Frosina G, Bergamini E 1985 Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes. Diabetologia 28:683-686
23. Tal M, Liang Y, Najafi H, Lodish HF, Matschinsky FM 1992 Expression and function of GLUT-1 and GLUT-2 glucose transporter isoforms in cells of cultured rat pancreatic islets. J Biol Chem 267:17241-17247
24. Thorens B, Weir GC, Leahy JL, Lodish HF, Bonner-Weir S 1990 Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic β-cells of diabetic rats. Proc Natl Acad Sci USA 87:6492-6497
25. Tancrede G, Rousseau-Migneron S, Nadeau A 1983 Long-term changes in the diabetic state induced by different doses of streptozotocin in rats. Br J Exp Pathol 64:117-123
26. Simon OR, West ME 1992 Unstable diabetic state produced by a small dose of streptozotocin in rats. West Indian Med J 41:146-149
27. Iwase M, Nunoi K, Wakisaka M, Kikuchi M, Maki Y, Sadoshima S, Fujishima M 1991 Spontaneous recovery from non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin treatment in spontaneously hypertensive rats. Metabolism 40:10-14
28. Ar'Rajab A, Ahrén B 1993 Long-term diabetogenic effect of streptozotocin in rats. Pancreas 1:50-57
29. Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE 1967 Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med 126:201-205
30. Conlon JM, Deacon CF, Bailey CJ, Flatt PR 1986 Effects of a transplantable insulinoma upon regulatory peptide concentrations in the gastrointestinal tract of the rat. Diabetologia 29:334-338
31. Arison RN, Ciaccio EI, Glitzer MS, Cassuro JA, Pruss MP 1967 Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. Diabetes 16:51-56
32. Evans JS, Gerritsen GC, Mann KM, Owen SP 1965 Antitumor and hyperglycemic activity of streptozotocin and its cofactor. Cancer Chemother Rep 48:1-6
33. Schein PS, Connell MJO, Blom J, Hubbard S, Magrath IT, Bergevin P, Wiernik PH, Ziegler JL, DeVita VT 1974 Clinical antitumor activity and toxicity of streptozotocin. Cancer 34:993-1000
34. Delahunt B, Cartwright PR, Thornton A, Dady PJ 1995 Proliferation kinetics of streptozotocin-induced renal tumours in mice. Virchows Arch 425:577-582